Advertisement

Author: Physician's Weekly Admin

Oral Roxadustat in CKD Patients with Anemia

Roxadustat acts as a HIF prolyl-hydroxylase inhibitor and increases the endogenous production of erythropoietin and stimulates the production of hemoglobin in red blood cells. The objective of this study is to evaluate the...

Read More

Systolic BP with Risk of Incident CKD

Chronic kidney disease (CKD) and hypertension are closely associated with each other. A few studies suggest that in addition to hypertension, temporal trends in systolic BP could be a potential risk factor of kidney function...

Read More

Outcomes of Canagliflozin by Baseline Kidney Function

Canagliflozin is an oral medication that helps control blood sugar levels by helping kidneys get rid of glucose from your bloodstream. Besides, the mediation also aids in reducing cardiovascular and renal events in patients with...

Read More

Glomerular Filtration Rate in Healthy Aging

Glomerular filtration rate (GFR) is an indicator of kidney function and is often assessed to confirm the presence of kidney disease. GFR is typically lower in older adults, but if healthy aging is associated with lower or...

Read More

Obstructive Sleep Apnea and the Risk of CKD

Obstructive sleep apnea (OSA) is a sleep disorder in which breathing repeatedly stops and resumes during sleep. Although the common complications of OSA are hypertension and cardiovascular disease, OSA may also lead to the...

Read More

For latest news and updates
Email-id is invalid